Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with hepatitis C virus genotype 1b
Author:
Affiliation:
1. Department of Hepatology; Osaka City University Graduate School of Medicine; Osaka Japan
2. Department of Gastroenterology; Osaka City Juso Hospital; Osaka Japan
3. Department of Hepatology; Osaka City General Hospital; Osaka Japan
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12689/fullpdf
Reference40 articles.
1. Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care;Pearlman;Lancet Infect Dis,2012
2. Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders;Imai;J Viral Hepat,2010
3. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection;Asahina;Hepatology,2010
4. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection;Hézode;N Engl J Med,2009
5. Telaprevir for previously treated chronic HCV infection;McHutchison;N Engl J Med,2010
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Trends in hepatitis C virus‐associated mortality rates in Japan, 1998–2017;Journal of Gastroenterology and Hepatology;2021-05
2. Intention‐to‐treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world;Hepatology Research;2019-08-09
3. Cost-effectiveness analyses of anti-hepatitis C virus treatments using quality of life scoring among patients with chronic liver disease in Hiroshima prefecture, Japan;Hepatology Research;2018-02-17
4. The presence of multiple NS 5A RAS s is associated with the outcome of sofosbuvir and ledipasvir therapy in NS 5A inhibitor‐naïve patients with chronic HCV genotype 1b infection in a real‐world cohort;Journal of Viral Hepatitis;2018-01-17
5. Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination;Annals of Hepatology;2017-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3